9 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Prevail Therapeutics Funding History

Since Prevail Therapeutics was founded in 2017, it has participated in 3 rounds of funding. In total Prevail Therapeutics has raised $250.0M. Prevail Therapeutics' last funding round was on Jun 2019 for a total of $125.0M.

Prevail Therapeutics Funding Rounds

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

IPO
Jun 2019
$125M
1
Series B
Mar 2019
$50M
9
OrbiMed,  Pontifax,  EcoR1 Capital,  RA Capital Management,  Omega Funds,  BVF Partners L.P,  Adage Capital Management L.P,  Alexandria Venture Investments,  Surveyor Capital
Series A
Mar 2018
$75M
7
OrbiMed,  Pontifax Venture Capital,  RA Capital Management,  EcoR1 Capital LLC,  Omega Funds,  BVF Partners L.P.,  Adage Capital Management, L.P.

Total Funding: $250M

Prevail Therapeutics Investors

Unlock 10 more investors →

INVESTOR

ROUND

FUNDING DATE

OrbiMed
Series B, Series A
Mar 2019, Mar 2018
Pontifax
Series B
Mar 2019
EcoR1 Capital
Series B
Mar 2019
RA Capital Management
Series B, Series A
Mar 2019, Mar 2018
Omega Funds
Series B, Series A
Mar 2019, Mar 2018

Total Investors: 13

Prevail Therapeutics has 13 investors, including OrbiMed, Pontifax and EcoR1 Capital. The latest investment occurred in Jun 2019.